Publication Beamlines Strategic Pillar
Joan Seoane Suarez; Judit ANIDO FOLGUEIRA; Robin Matthew Hallett; Peter Edward BAYLISS; Ajitha JEGANATHAN et al. (2021). Methods for improving response to anti-lif antibody treatment in individuals with cancer. Patent Number: US20210253691A1. CMCF-ID Health
John Lippincott; Kelsey Sivick Gauthier; Nigel Pelham Clinton Walker; Xiaoning Zhao (2023). ANTIBODIES FOR TIGIT.. Patent Number: MX2022015157A.
John Robert Porter; Alastair Lawson; Daniel John Lightwood; Rebecca Jayne Wootton; James Philip O'connell et al. (2018). Antibody. Patent Number: CL2017003246A1.
Jorg Stetefeld (2020). Netrin- 1 and dependence receptor proteins and method of use. Patent Number: US20200165308A1. CMCF-BM Health
Jorg Stetefeld (2016). Netrin-1 and dependence receptor proteins and methods of use. Patent Number: US20160355560A1. CMCF-BM Health
Jorg STETEFELD (2015). Netrin-1 and dependence receptor proteins and methods of use. Patent Number: WO2015118514A1.
J·P·奥康奈尔; J·R·波特; A·劳森; B·克勒普林; S·E·拉佩基 et al. (2021). Mechanism. Patent Number: CN107771286B.
J·P·奥康奈尔; J·R·波特; A·劳森; B·克勒普林; S·E·拉佩基 et al. (2022). Mechanism of action. Patent Number: CN111574517B.
J·P·奥康奈尔; J·R·波特; A·劳森; B·克罗普里恩; S·E·拉佩奇 et al. (2021). Modulator assay. Patent Number: CN107810419B.
J·P·奥康奈尔; J·R·波特; A·劳森; D·J·莱特伍德; R·J·伍顿 et al. (2022). Antibodies. Patent Number: CN108290945B.
J·P·奥康奈尔; J·R·波特; A·劳森; T·L·阿拉卡基; D·J·莱特伍德 et al. (2020). Antibody epitopes. Patent Number: CN108139407B.
Juan P. Ianowski; Julian S. Tam; Xiaojie Luan; Veronica A. Campanucci (2021). Neuronal agonists and isotonic or hypertonic saline for treating respiratory diseases. Patent Number: US20210228511A1. BMIT-BM Health
Judit Anido Folgueira; Ester BONFILL TEIXIDOR; Johan Fransson; Robin Matthew Hallett; Monica PASCUAL GARCIA et al. (2024). Combination of LIF inhibitors and PD-1 axis inhibitors for use in treating cancer. Patent Number: AU2019251289B2.
Judit Anido Folgueira; Patricia Anne Giblin; Robin Matthew Hallett; Jeanne Magram; Naimish PANDYA et al. (2024). Combination of lif inhibitors and platinum-based antineoplastic agents for use in treating cancer. Patent Number: AU2024204564A1. CMCF-ID Health
Judit Anido Folgueira; Patricia Anne Giblin; Robin Matthew Hallett; Jeanne Magram; Naimish PANDYA et al. (2024). Combination of LIF inhibitors and platinum-based antineoplastic agents for use in treating cancer. Patent Number: AU2019291307B2.